115 results
DEFR14A
ARAV
Aravive Inc
22 Sep 23
Revised proxy
5:04pm
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting … , if Other Than the Registrant)
Payment of Filing Fee (check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee
8-K
EX-10.1
hm3 rsvvooh
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
D
7pduo2zc
28 Oct 22
$41.56 mm in equity / options / securities to be acquired, sold $41.56 mm, 17 investors
4:11pm
8-K/A
EX-10.1
svmy wvfy87yjd1kkl5
28 Oct 22
Other Events
4:05pm
8-K
EX-10.2
nid31hd61e1w2fyvyswg
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
po4jg10
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
bs0cd7sd1 nw7
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.2
f1d8 56f23zusuu005
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.1
gpy4fhpd
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm